Search hospitals > Missouri > Springfield
Clinvest Research LLC
Claim this profileSpringfield, Missouri 65807
Global Leader in Migraine
Global Leader in Headache
Conducts research for Arthritis
Conducts research for Diabetes
Conducts research for Type 2 Diabetes
142 reported clinical trials
3 medical researchers
Summary
Clinvest Research LLC is a medical facility located in Springfield, Missouri. This center is recognized for care of Migraine, Headache, Arthritis, Diabetes, Type 2 Diabetes and other specialties. Clinvest Research LLC is involved with conducting 142 clinical trials across 65 conditions. There are 3 research doctors associated with this hospital, such as David Gregory True, David True, MD, and Ralph Joseph Duda.Top PIs
David Gregory TrueClinvest Research LLC2 years of reported clinical research
Studies Neuralgia
Studies Diabetic Neuropathy
23 reported clinical trials
25 drugs studied
David True, MDClinvest Research LLC2 years of reported clinical research
Studies Migraine
Studies Obesity
14 reported clinical trials
15 drugs studied
Ralph Joseph DudaClinvest Research LLC2 years of reported clinical research
Studies Diabetes
Studies Type 2 Diabetes
4 reported clinical trials
4 drugs studied
Clinical Trials running at Clinvest Research LLC
Migraine
Obesity
Cardiovascular Disease
Type 2 Diabetes
Rheumatoid Arthritis
Diabetes
Arthritis
Osteoarthritis
Obstructive Sleep Apnea
Diabetic Neuropathy
Rimegepant
for Migraine
This study is being conducted to evaluate the efficacy and tolerability of rimegepant in a population of adults that are unsuitable for triptan medications due to a previous intolerance, lack of efficacy, or contraindication (including a history of clinically-relevant cardiovascular disease).
Recruiting2 awards Phase 4
Rimegepant
for Migraine Prevention
This study is being conducted to evaluate the efficacy and tolerability of rimegepant for migraine prophylaxis in adults with a history of inadequate response to oral preventive medications
Recruiting2 awards Phase 41 criteria
Rimegepant
for Pediatric Migraine
This trial aims to test the safety of rimegepant, a medication for treating migraines. The study focuses on children and adolescents aged 6 to 17 years who experience moderate to severe migraines. Rimegepant works by blocking a protein that triggers migraine pain, helping to alleviate symptoms.
Recruiting2 awards Phase 38 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Clinvest Research LLC?
Clinvest Research LLC is a medical facility located in Springfield, Missouri. This center is recognized for care of Migraine, Headache, Arthritis, Diabetes, Type 2 Diabetes and other specialties. Clinvest Research LLC is involved with conducting 142 clinical trials across 65 conditions. There are 3 research doctors associated with this hospital, such as David Gregory True, David True, MD, and Ralph Joseph Duda.